Charles Schwab’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Charles Schwab’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-36,520	Closed	-$372K	–	3606
2023 Q3	$372K	Hold	36,520	–	–	﹤0.01%	3155
2023 Q2	$172K	Hold	36,520	–	–	﹤0.01%	3319
2023 Q1	$169K	Buy	36,520 +2,304	+7%	+$10.1K	﹤0.01%	3181
2022 Q4	$124K	Hold	34,216	–	–	﹤0.01%	3238
2022 Q3	$162K	Hold	34,216	–	–	﹤0.01%	3186
2022 Q2	$166K	Buy	34,216 +19,586	+134%	+$119K	﹤0.01%	3254
2022 Q1	$94K	Hold	14,630	–	–	﹤0.01%	3424
2021 Q4	$91K	Buy	+14,630	New	+$114K	﹤0.01%	3448

Charles Schwab's THRN Position: Q4 2023 in Review

Charles Schwab sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 36,520 shares — an estimated $372K sold.

Charles Schwab first reported a position in THRN in Q4 2021 and held it in 8 quarters. The position peaked at $372K in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

Charles Schwab reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Charles Schwab sold 36,520 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $372K.
Charles Schwab first reported a position in Thorne Healthtech, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Charles Schwab's Thorne Healthtech, Inc. Common Stock position peaked at $372K in Q3 2023.
0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.